证券代码：002338 证券简称：奥普光电 长春奥普光电技术股份有限公司 投资者关系活动记录表 编号：2023-05-005 投资者关系活动 特定对象调研 □分析师会议 类别 □媒体采访 业绩说明会 □新闻发布会 □路演活动 现场参观 其他 （走进上市公司·投资者开放日活动） 参与单位名称及 深圳证券交易所投资者服务部；东北证券、平安证券组织的 人员姓名 投资者；部分机构投资者 时间 2023 年 5 月 31 日 14：30-16：30 地点 长春禹衡光学有限公司 上市公司接待人 董事会秘书 沈娟 证券事务代表 周健 员姓名 禹衡光学总经理助理 武平 禹衡光学市场经理 董岩 一、禹衡光学负责人带领与会者参观了长春禹衡光学有限公司 展厅及生产车间。 二、董事会秘书沈娟女士介绍了公司概况，内容包括：公司 的发展历程、经营业绩、主要产品与客户、核心竞争优势、研 投资者关系活动 发制造能力、发展前景等。 主要内容介绍 三、现场互动交流 1.奥普光电未来三到五年战略规划和发展方向是怎么样的？ 未来三到五年，我们主要是在做好现有传统业务的基础上，布 局新的方向。目前布局的几个方向有：半导体方向，母公司有 一些技术在半导 ...

证券代码：002338 证券简称：奥普光电 长春奥普光电技术股份有限公司 投资者关系活动记录表 编号：2023-05-004 投资者关系活动 特定对象调研 □分析师会议 类别 □媒体采访 业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 参与单位名称及 中金公司 杨倩雯 德邦证券 唐保威 人员姓名 中欧基金 薛承沛 中海基金 周天昊 德邦证券 陈瑞基 德邦证券 何思源 民生证券 罗 松 时间 2023 年 5 月 25 日 地点 公司三楼会议室 上市公司接待人 董事会秘书 沈娟 财务负责人 徐爱民 员姓名 证券事务代表 周健 财务部经理 田光宗 长光宇航副总经理 商伟辉 1. 禹衡光学高端光栅尺领域与海德汉的差距如何？国内外竞 争情况如何？ 禹衡光学光栅尺目前从精度上来说，基本可以和海德汉进行对 标；从技术实力上，还是有一定的差距。绝对式光栅尺以及角 投资者关系活动 度编码器，无论是精度性能还是使用范围，都已经达到了国际 主要内容介绍 上的先进水平，国内的领先水平。 2.下游客户主要有国内那些知名厂商？伺服产品今年增速预 计？ 禹衡光学下游客户主要有华中数控、广数、科德数控等。伺服 产品属于量大利薄的 ...

证券代码： 002338 证券简称：奥普光电 长春奥普光电技术股份有限公司 投资者关系活动记录表 编号：2023-05-003 | 投资者关系活动 | 分析师会议 □特定对象调研 □ | | --- | --- | | 类别 | □ 媒体采访 √ 业绩说明会 | | | □ 新闻发布会 □ 路演活动 | | | □ 现场参观 | | | 其他 （请文字说明其他活动内容） □ | | 参与单位名称及 | 投资者网上提问 | | 人员姓名 | | | 时间 | 2023 年 5 月 22 日 (周一) 下午 14:00~16:00 | | 地点 | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | | 采用网络远程的方式召开业绩说明会 | | 上市公司接待人 | 总经理高劲松 财务负责人徐爱民 | | 员姓名 | 董事会秘书沈娟 证券事务代表周健 | | | 公司就投资者在本次说明会中提出的问题进行了回复： | | | 1、目前很多公司都自愿披露即时的经营情况，利于投资者 | | | 更及时了解上市公司，请问公司四月份的经营情况如何？谢谢 | | | 公司 4 月份生产经营正常 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，简 明清晰、通俗易懂，没有虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，长春奥普光电技术股份有限公司（以下 简称"公司"）将参加由吉林证监局、吉林省证券业协会、深圳市全景网络有限 公司共同举办的"2023年吉林辖区上市公司网上集体业绩说明会"，现将有关事 项公告如下： 本次集体业绩说明会将通过深圳市全景网络有限公司提供的互联网平台举 行，投资者可以登陆"全景网"投资者关系互动平台"（http://ir.p5w.net） 参与公司业绩说明会,时间为2023年5月22日（星期一）14:00 至 16:00。 届时公司总经理高劲松先生、财务负责人徐爱民先生、董事会秘书沈娟女士 将通过网络在线问答互动的形式，与投资者就2022年经营业绩等投资者关注的问 题进行交流。期间，公司高管将全程在线，实时回答投资者的提问。 投资者可于2023年5月19日（星期五）17：00 前访问https://ir.p5w.net/zj/， 或扫描下方二维码，进入问题征集专题页面，欢迎广大投资者积极参与。 证券代码：002338 证券简称：奥普光电 公告编号：20 ...

否。 5、请问公司控股参股的企业所生产的光栅传感器、K9 光 学玻璃，能否作为国产光刻机的零配件？ 从原理上光栅传感器、光学玻璃都可应用于光学系统。 证券代码：002338 证券简称：奥普光电 长春奥普光电技术股份有限公司 投资者关系活动记录表 编号：2023-05-002 | 投资者关系活动 | □特定对象调研 □分析师会议 | | --- | --- | | 类别 | □媒体采访 业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 | | 参与单位名称及 人员姓名 | 参与公司 2022 年度网上业绩说明会的投资者 | | 时间 | 2023 年 5 月 8 日 15:00-17:00 | | 地点 | 公司通过全景网"投资者关系互动平台" | | | （https://ir.p5w.net）采用网络远程的方式召开业绩说明 | | | 会 | | 上市公司接待人 | 董事长孙守红、总经理高劲松、董事会秘书沈娟、财务负责人 | | 员姓名 | 徐爱民、独立董事马飞 公司就投资者在本次说明会中提出的问题进行了回复： | | | 1、公司有什么产品可以应用于 Ai 服 ...

Financial Performance - The company's revenue for Q1 2023 was CNY 189,742,084.40, representing a year-on-year increase of 63.57% compared to CNY 115,999,886.79 in the same period last year[5] - Net profit attributable to shareholders was CNY 21,104,494.68, reflecting a year-on-year growth of 23.04% from CNY 17,152,070.98[5] - Basic and diluted earnings per share increased by 28.57%, reaching CNY 0.09 per share compared to CNY 0.07 per share in the previous year[5] - Net profit for Q1 2023 was ¥31,693,941.40, representing a 81.7% increase from ¥17,472,969.70 in Q1 2022[18] - The total comprehensive income for the first quarter was CNY 31,693,941.40, compared to CNY 17,472,969.70 in the previous year, representing an increase of approximately 81.2%[19] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,960,228,954.66, a 1.51% increase from CNY 1,931,047,733.20 at the end of the previous year[5] - The company's total assets as of March 31, 2023, amounted to ¥1,960,228,954.66, up from ¥1,931,047,733.20 at the beginning of the year[15] - Current assets totaled ¥1,002,806,740.28, showing a slight increase from ¥991,931,796.62 at the start of the year[14] - Total liabilities decreased slightly to ¥582,767,228.40 from ¥585,279,948.34 at the beginning of the year[15] - The equity attributable to shareholders increased to ¥1,157,855,214.88 from ¥1,136,750,720.20, marking a growth of 1.9%[15] Cash Flow - The net cash flow from operating activities decreased by 302.55%, amounting to CNY -106,298,608.49, primarily due to reduced sales collections and increased cash payments for production preparations and raw material inventory[8] - The net cash flow from operating activities was negative CNY 106,298,608.49, worsening from negative CNY 26,406,165.49 in the same period last year[21] - Cash inflow from operating activities totaled CNY 103,607,996.93, while cash outflow was CNY 209,906,605.42, leading to a significant cash outflow[21] - Investment activities generated a net cash flow of CNY 22,658,085.12, a turnaround from a negative cash flow of CNY 10,382,492.50 in the previous year[21] - The cash and cash equivalents at the end of the period were CNY 56,975,004.30, down from CNY 99,570,954.49 at the end of the previous year[21] Operational Metrics - Operating costs for Q1 2023 were ¥169,185,527.48, up 52.5% from ¥110,877,403.68 in Q1 2022[17] - Accounts receivable increased to ¥275,011,592.26 from ¥214,341,463.74, indicating a growth of 28.3%[13] - Inventory levels rose to ¥430,655,049.93, compared to ¥422,216,706.31 at the beginning of the year, reflecting a 2.9% increase[14] - The company reported R&D expenses of ¥14,801,723.34, which is a 64.5% increase from ¥9,002,901.97 in the previous year[18] - The company reported a significant increase in cash outflow related to operating activities, with payments to employees rising to CNY 67,274,111.69 from CNY 43,809,818.50[21] Shareholder Information - The company's equity attributable to shareholders was CNY 1,157,855,214.88, up 1.86% from CNY 1,136,750,720.20 at the end of the last year[5] - The total number of ordinary shareholders at the end of the reporting period was 24,107[10] Non-Recurring Items - Non-recurring gains and losses amounted to CNY 2,753,787.23, including government subsidies of CNY 4,111,524.65[6] Audit Information - The company did not conduct an audit for the first quarter report[22]

Financial Performance - The company's operating revenue for 2022 was CNY 627,063,933, representing a 14.67% increase compared to CNY 546,849,229 in 2021[21]. - The net profit attributable to shareholders for 2022 was CNY 81,793,106, a significant increase of 75.31% from CNY 46,657,302 in the previous year[21]. - The basic earnings per share for 2022 rose to CNY 0.34, up 78.95% from CNY 0.19 in 2021[21]. - The net cash flow from operating activities increased by 36.37% to CNY 60,384,182 in 2022, compared to CNY 44,279,257 in 2021[21]. - Total assets at the end of 2022 reached CNY 1,931,047,733, marking a 64.33% increase from CNY 1,175,124,999 in 2021[21]. - The net assets attributable to shareholders increased by 20.75% to CNY 1,136,750,720 at the end of 2022, compared to CNY 941,403,511 in 2021[21]. - The company reported a significant decrease in non-recurring gains and losses, with a net profit of CNY 377,467, down 98.83% from the previous year[21]. - The weighted average return on net assets for 2022 was 7.88%, an increase from 5.90% in 2021[21]. - The company reported a total revenue of 3,676,865,000 CNY for the year 2022, reflecting a significant growth compared to the previous year[40]. - The company reported a significant increase in revenue, reaching 56,045,865 million CNY for the year 2022, compared to the previous year[41]. - The company reported a total revenue of 60.25 million in 2022, reflecting a year-on-year growth of 15%[43]. - The company reported a revenue of 354.7 million in 2022, with a net profit of 83.57 million, representing a year-on-year increase of 46.46% and 98.55% respectively[83]. - The company reported a total of 8,000 shares held by departing director Li Yaobin, with no changes in holdings during the reporting period[106]. Dividends and Profit Distribution - The company plans to distribute a cash dividend of CNY 0.1 per 10 shares, totaling CNY 24,000,000 based on 240,000,000 shares[4]. - The company has a cash dividend policy in place, with a total cash dividend amount of CNY 2,400,000, which is 100% of the total profit distribution[142]. - The available profit for distribution as of December 31, 2022, is CNY 251,989,561.05, after accounting for the net profit and previous dividends[143]. Market Strategy and Expansion - The company aims to achieve a revenue growth target of 15% for the next fiscal year, driven by new product launches and market expansion strategies[40]. - The company is focusing on expanding its product lines, including optical glass and medical devices, to enhance market presence[40]. - The company plans to increase its market share through strategic acquisitions and partnerships in the coming years[40]. - The company is exploring opportunities in international markets to diversify its revenue streams and reduce dependency on domestic sales[40]. - The company plans to enhance its market strategy through potential mergers and acquisitions to strengthen its competitive position[42]. - The company is focusing on expanding its market presence in Southeast Asia, targeting a 10% market share by 2025[44]. - The company is expanding its market presence in Europe, targeting a 30% market share by 2025[112]. - The company is considering strategic acquisitions to enhance its technology portfolio, with a budget of 300 million yuan allocated for potential deals[120]. Research and Development - The company is committed to advancing its product offerings, including high-precision optical measurement devices used in missile and satellite tracking[35]. - Research and development efforts are being intensified, with a focus on innovative solutions in optical and medical technology[40]. - The R&D investment for new products and technologies increased by 25% in 2022, totaling 5 million[44]. - The company invested $20 million in new technology development, focusing on AI and machine learning applications[112]. - The company is focusing on developing new optical tracking devices and rapid biological analysis technologies to enhance its product offerings and market position[63]. - The company aims to achieve full domestic production of high-resolution imaging devices, which is expected to create new profit growth points[63]. - The company has launched over 10 new patents and technologies annually, with many reaching domestic leading and international advanced levels[48]. Corporate Governance - The company is committed to improving corporate governance in accordance with relevant laws and regulations[93]. - The company maintains independent operations from its controlling shareholder, with no instances of fund occupation or guarantees provided to the controlling shareholder[95]. - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with legal procedures and enhancing governance[96]. - The company has established a robust internal management system to ensure compliance with governance standards[93]. - The company has implemented a profit compensation mechanism for any shortfall in promised profits during the compensation period[167]. - The company emphasizes transparent communication with investors, ensuring fair participation in shareholder meetings and protecting minority shareholders' rights[160]. Employee Development and Compensation - The company has a structured remuneration decision-making process based on performance evaluations and board approvals[126]. - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to CNY 449.65 million[128]. - The company focuses on employee development and well-being, providing competitive compensation and a robust training system for new hires[161]. - A comprehensive employee training system is established, focusing on new employee onboarding and ongoing skill development for current employees[140]. - The company has implemented proactive talent policies to retain core employees and attract external talent, ensuring a high-quality workforce[88]. Environmental Responsibility - The company has committed to environmental protection as part of its sustainable development strategy, improving resource utilization and reducing energy consumption[161]. - The company has invested approximately 500,000 yuan in environmental protection and energy-saving measures during the reporting period[157]. - The company has implemented a chemical reduction and precipitation method for wastewater treatment, ensuring compliance with discharge standards[154]. - The company has established an emergency response plan for environmental pollution incidents and conducts annual drills[156]. - The company has no record of administrative penalties due to environmental issues during the reporting period[159]. Strategic Acquisitions - The company completed the acquisition of Changchun Changguang Aerospace Composite Materials Co., Ltd., increasing its stake to 51.11%, which enhances its capabilities in high-performance carbon fiber products[57]. - The company made a significant equity investment of CNY 800,000,000 in Changchun Yuheng Optical Co., Ltd., holding a 51.1% stake[75]. - The company acquired controlling interest in Changchun Changguang Aerospace Composite Materials Co., enhancing its product offerings in aerospace and military sectors[84]. Challenges and Risks - The company has faced uncertainties regarding its ability to continue as a going concern, as indicated by the negative net profit figures over the last three accounting years[24]. - The company has not reported any penalties from securities regulatory agencies for its directors, supervisors, and senior management in the past three years[125]. - The company has no issues related to the self-inspection of corporate governance actions[151].

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，简 明清晰、通俗易懂，没有虚假记载、误导性陈述或重大遗漏。 长春奥普光电技术股份有限公司（以下简称"公司"）定于2023年5月8日（周 一）下午 15：00—17：00 在全景网举办2022年度业绩说明会，本次年度业绩说 明会将采用网络远程的方式举行，投资者可登陆全景网"投资者关系互动平台" （http://ir.p5w.net）参与本次年度业绩说明会。 出席本次说明会的人员有：董事长孙守红先生、总经理高劲松先生、董事会 秘书沈娟女士、财务负责人徐爱民先生、独立董事马飞先生。 为充分尊重投资者、提升交流的针对性，现就公司2022年度业绩说明会提前 向投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于2023年5月5 日（星期五）16:00前访问 http://ir.p5w.net/zj/，或扫描下方二维码，进入 问题征集专题页面。公司将在2022年度业绩说明会上，对投资者普遍关注的问题 进行回答。 欢迎广大投资者积极参与本次网上说明会。 证券代码：002338 证券简称：奥普光电 公告编号：2023-015 长春奥普光电技术股份有限公司 关于举 ...